Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Neil A Galloway-Phillipps"'
Autor:
Rekha Badiger, Jane A Mitchell, Hime Gashaw, Neil A Galloway-Phillipps, Stefan Foser, Fernando Tatsch, Thomas Singer, Trevor T Hansel, Tobias Manigold
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46779 (2012)
Alfa-interferons (IFNα2a, IFNα2b, 40KDa-PEGIFNα2a and 12KDa-PEGIFNα2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumonitis and p
Externí odkaz:
https://doaj.org/article/8b3d9158413b4a5190c0cfc5b2c0d180
Autor:
Trevor T. Hansel, Clare L. Ross, Tanushree Tunstall, Onn Min Kon, Mark J. Paul-Clark, Paul C Armstrong, Mari Ito, Jane A. Mitchell, Sarah L. Elkin, Neil A. Galloway-Phillipps, Christopher Brearley, Timothy D. Warner
Publikováno v:
BMJ Open
e005750
e005750
Introduction Cigarette smoke contributes to a diverse range of diseases including chronic obstructive pulmonary disease (COPD), cardiovascular disorders and many cancers. There currently is a need for human challenge models, to assess the acute effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b63abde3a9b790b125515faf97300d
https://pubmed.ncbi.nlm.nih.gov/25631307
https://pubmed.ncbi.nlm.nih.gov/25631307
Autor:
Morven Cunningham, Neil A. Galloway-Phillipps, Rekha Badiger, Graham R. Foster, Jane A. Mitchell, Peter M. George, William Alazawi
Publikováno v:
Pulmonary Circulation
Endothelin-1 is a potent vasoconstrictor and a therapeutic target in pulmonary arterial hypertension. Endothelial cells are the physiological source of endothelin-1 but in vitro data from our group shows that interferons (IFNα, IFNβ or IFNγ) induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d92a4065a5688efcdf8afefcff7218a4
https://pubmed.ncbi.nlm.nih.gov/23372935
https://pubmed.ncbi.nlm.nih.gov/23372935
Autor:
Neil A. Galloway-Phillipps, Thomas Singer, Jane A. Mitchell, Stefan Foser, Tobias Manigold, Fernando Tatsch, Rekha Badiger, Trevor T. Hansel, Hime Gashaw
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e46779 (2012)
PLoS ONE
PLoS ONE
Background Alfa-interferons (IFNα2a, IFNα2b, 40KDa-PEGIFNα2a and 12KDa-PEGIFNα2b) are effective treatments for chronic hepatitis C infection. However, their usage has been associated with a variety of adverse events, including interstitial pneumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e544a2f4fb34a7d97b3a43b0e040b2ef
https://doi.org/10.1371/journal.pone.0046779
https://doi.org/10.1371/journal.pone.0046779